Demographic characteristics, tumor pathology, and clinical staging of 34 patients with DLBCL or FL.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
IPI (International Prognostic Index) was used for the evaluation of DLBCL. IPI 1: low risk; IPI 2: low-intermediate risk; IPI 3: high-intermediate risk; IPI 4: high risk. * FLIPI (Follicular Lymphoma International Prognostic Index) was used for FL. FLIPI 0–1: low risk; FLIPI 2: intermediate risk; FLIPI≥3: high risk.
创建时间：
2014-01-15
